Literature DB >> 8726250

Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation.

F M Santorelli1, S C Mak, M E Vazquez-Memije, S Shanske, P Kranz-Eble, K D Jain, D L Bluestone, D C De Vivo, S DiMauro.   

Abstract

The mitochondrial DNA (mtDNA) point mutation T8993G has been associated with maternally inherited Leigh syndrome (MILS) when very abundant (> 95%). MILS patients are usually severely affected and die in early infancy. In 1993, a novel T8993C point mutation was described in a juvenile form of Leigh syndrome (LS) characterized by a less aggressive clinical course. We describe four unrelated T8993C patients who had diverse, relatively mild, clinical manifestations. Polymerase chain reaction-restriction fragment length polymphorphism analysis showed that the heteroplasmic T8993C point mutation was very abundant in several tissues from all four patients (94.2 +/- 1.5%) but was less copious in blood from 20 maternal relatives. ATP production in mitochondria isolated from skin fibroblasts in three patients was normal, whereas in one patient it was decreased to 20-35% of controls. These findings suggest that the T8993C mutation is less severe than the more common T8993G mutation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726250     DOI: 10.1203/00006450-199605000-00028

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

1.  Leigh syndrome in a 3-year-old boy with unusual brain MR imaging and pathologic findings.

Authors:  M Topçu; I Saatci; R A Apak; F Söylemezoglu; Z Akçören
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells.

Authors:  M D'Aurelio; C Vives-Bauza; M M Davidson; G Manfredi
Journal:  Hum Mol Genet       Date:  2009-10-29       Impact factor: 6.150

Review 3.  Compromised fatty acid oxidation in mitochondrial disorders.

Authors:  L Hagenfeldt
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

4.  Fulminant Leigh syndrome and sudden unexpected death in a family with the T9176C mutation of the mitochondrial ATPase 6 gene.

Authors:  C Dionisi-Vici; S Seneca; M Zeviani; G Fariello; M Rimoldi; E Bertini; L De Meirleir
Journal:  J Inherit Metab Dis       Date:  1998-02       Impact factor: 4.982

Review 5.  MT-ATP6 mitochondrial disease variants: Phenotypic and biochemical features analysis in 218 published cases and cohort of 14 new cases.

Authors:  Rebecca D Ganetzky; Claudia Stendel; Elizabeth M McCormick; Zarazuela Zolkipli-Cunningham; Amy C Goldstein; Thomas Klopstock; Marni J Falk
Journal:  Hum Mutat       Date:  2019-03-04       Impact factor: 4.878

6.  Illness-induced exacerbation of Leigh syndrome in a patient with the MTATP6 mutation, m. 9185 T>C.

Authors:  Russell P Saneto; Keshav K Singh
Journal:  Mitochondrion       Date:  2010-05-27       Impact factor: 4.160

Review 7.  Mitochondrial encephalomyopathies: what next?

Authors:  S DiMauro
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

8.  Adaptive optics scanning laser ophthalmoscopy images in a family with the mitochondrial DNA T8993C mutation.

Authors:  Michael K Yoon; Austin Roorda; Yuhua Zhang; Chiaki Nakanishi; Lee-Jun C Wong; Qing Zhang; Leslie Gillum; Ari Green; Jacque L Duncan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-07       Impact factor: 4.799

9.  Fatty acid oxidation in fibroblasts from patients with defects in beta-oxidation and in the respiratory chain.

Authors:  N Venizelos; U von Döbeln; L Hagenfeldt
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 10.  Mitochondrial DNA disease-molecular insights and potential routes to a cure.

Authors:  Oliver Russell; Doug Turnbull
Journal:  Exp Cell Res       Date:  2014-03-24       Impact factor: 3.905

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.